Predicting response to EGFR-tyrosine kinase inhibitors among diverse ancestries: Just way too polymorphic
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 2007
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents (MeSH)
- Drug Resistance, Neoplasm (MeSH)
- ErbB Receptors (MeSH)
- Humans (MeSH)
- Neoplasms (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Polymorphism, Genetic (MeSH)
- Protein Kinase Inhibitors (MeSH)
published in
- Cancer Biology and Therapy Journal